Ledger.Open graph →
SEC Form D · filed August 29, 2016

IMPEL NEUROPHARMA INC

Offering
$2.0M
Sold
$1.1M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
SEATTLE, WA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Stewart D. Parker · Seattle, WADirectorJohn D. Hoekman · Seattle, WAExec · DirectorHGI Opportunity Select Fund V Managing Co., LLC · Norfolk, VAExec · DirectorPhilip Warth · San Clemente, CADirectorJohn Corpus · Denver, COExec · DirectorHGI US Property Fund IX Managing Co., LLC · Norfolk, VADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗